Treatment patterns of hormone therapy for menopause-associated vasomotor symptoms: analysis of the HIRA database in South Korea
While the number of patients who received HT constituted approximately 1% of the estimated 9.31 million menopausal population in South Korea, most patients prescribed HT had a medical condition of interest at baseline that was a contraindication or precaution for HT. There is a need to identify additional well-tolerated, effective alternatives.
Authors
- Cindy Thiow Koon Lim (ORCID: https://orcid.org/0000-0001-7408-2422)
- Cho Gj
- Robert Snijder (ORCID: https://orcid.org/0000-0002-5495-8287)
- Mohamed A. R. Soliman (ORCID: https://orcid.org/0000-0003-1855-2551)
- Soyoung Kim (ORCID: https://orcid.org/0000-0002-8678-5341)
- Farid Abdul Hadi
- Sharon Yu Lin Chua
Institutions
- Astellas Pharma (Japan) (JP)
- Korea University Medical Center (KR)
- Astellas Pharma (China) (CN)
- Astellas Pharma (Germany) (DE)
- IQ Solutions (US)
- Astellas Pharma (Netherlands) (NL)
Publication Details
- Journal
- Climacteric
- Published
- 2026-02-11
- DOI
- https://doi.org/10.1080/13697137.2026.2615389
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00